Cribstone Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Cribstone Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$37.1K	Hold	515	–	–	0.02%	175
2022 Q3	$37K	Hold	515	–	–	0.02%	172
2022 Q2	$40K	Hold	515	–	–	0.02%	167
2022 Q1	$38K	Hold	515	–	–	0.02%	177
2021 Q4	$32K	Hold	515	–	–	0.02%	185
2021 Q3	$30K	Buy	515 +16	+3%	+$1.05K	0.02%	182
2021 Q2	$33K	Hold	499	–	–	0.02%	180
2021 Q1	$32K	Hold	499	–	–	0.02%	171
2020 Q4	$31K	Hold	499	–	–	0.02%	173
2020 Q3	$30K	Sell	499 -162	-25%	-$9.75K	0.02%	141
2020 Q2	$39K	Hold	661	–	–	0.03%	136
2020 Q1	$37K	Sell	661 -400	-38%	-$24.4K	0.04%	124
2019 Q4	$68K	Sell	1,061 -2,040	-66%	-$117K	0.06%	125
2019 Q3	$157K	Sell	3,101 -470	-13%	-$22.1K	0.09%	124
2019 Q2	$162K	Sell	3,571 -85	-2%	-$3.96K	0.09%	127
2019 Q1	$174K	Sell	3,656 -2,450	-40%	-$122K	0.09%	117
2018 Q4	$317K	Hold	6,106	–	–	0.16%	92
2018 Q3	$379K	Hold	6,106	–	–	0.17%	91
2018 Q2	$338K	Buy	6,106 +100	+2%	+$5.4K	0.17%	95
2018 Q1	$380K	Buy	6,006 +2,470	+70%	+$159K	0.19%	88
2017 Q4	$217K	Sell	3,536 -70	-2%	-$4.38K	0.1%	119
2017 Q3	$230K	Hold	3,606	–	–	0.12%	103
2017 Q2	$201K	Sell	3,606 -222	-6%	-$12.1K	0.11%	112
2017 Q1	$204K	Hold	3,828	–	–	0.11%	116
2016 Q4	$188K	Sell	3,828 -203	-5%	-$11.1K	0.11%	110
2016 Q3	$203K	Sell	4,031 -50	-1%	-$3.21K	0.12%	102
2016 Q2	$300K	Buy	4,081 +67	+2%	+$4.73K	0.19%	86
2016 Q1	$256K	Sell	4,014 -225	-5%	-$14.2K	0.21%	88
2015 Q4	$287K	Buy	+4,239	New	+$280K	0.24%	80

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Cribstone Capital Management's BMY Position: Q4 2022 in Review

Cribstone Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q4 2022 at 515 shares worth $37.1K. The position accounts for 0.02% of the portfolio, ranked #175.

Cribstone Capital Management first reported a position in BMY in Q4 2015 and has held it in 29 quarters since. The position peaked at $380K in Q1 2018. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

Cribstone Capital Management held 515 shares of Bristol-Myers Squibb worth $37.1K as of Q4 2022.
Cribstone Capital Management left its Bristol-Myers Squibb share count unchanged in Q4 2022.
Bristol-Myers Squibb made up 0.02% of Cribstone Capital Management's portfolio in Q4 2022, its #175 holding.
Cribstone Capital Management first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 29 quarters since.
Cribstone Capital Management's Bristol-Myers Squibb position peaked at $380K in Q1 2018.
2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.